TOWA Pharmaceuticals Europe, S.L.

The medicine is used in adults for the treatment of depression, generalized anxiety disorder, and pain in diabetic neuropathy.

Dosage form: capsules, hard, intestinal

ATC: N06AX21

The medicinal product is used in adults for the treatment of depression, generalized anxiety disorder, and pain in diabetic neuropathy.

Dosage form: capsules, hard, intestinal

ATC: N06AX21

The medicine is used for the treatment of, among others, gastric and duodenal ulcers (including Helicobacter pylori infection), reflux esophagitis, heartburn, Zollinger-Ellison syndrome, and for the prevention of ulcers caused by anti-inflammatory drugs (NSAIDs).

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or the use of non-steroidal anti-inflammatory drugs [NSAIDs]), as well as Zollinger-Ellison syndrome.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used in adults for the short-term treatment of gastroesophageal reflux symptoms, such as heartburn and acid regurgitation.

Dosage form: capsules, hard, intestinal

ATC: A02BC05

The medicine is used to treat gastroesophageal reflux disease (manifesting as heartburn, pain, and inflammation), gastric or intestinal ulcer disease (also caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive gastric acid secretion caused by a pancreatic tumor.

Dosage form: capsules, hard, intestinal

ATC: A02BC05

The medicine is used to treat gastroesophageal reflux disease (manifesting, among other things, as heartburn and pain), gastric or intestinal ulcer disease (also caused by Helicobacter pylori bacteria or anti-inflammatory drugs), as well as in cases of excessive gastric acid secretion caused by a pancreatic tumor.

Dosage form: capsules, hard, intestinal

ATC: A02BC05

The medicine is used for the treatment of gastroesophageal reflux disease (heartburn, regurgitation of gastric contents), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), and in cases of excessive acid secretion in Zollinger-Ellison syndrome.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used to treat gastroesophageal reflux disease (heartburn, regurgitation of gastric contents), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive acid secretion in Zollinger-Ellison syndrome.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used to treat gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers (including those caused by Helicobacter pylori bacteria or non-steroidal anti-inflammatory drugs [NSAIDs]), as well as in cases of excessive acid secretion in Zollinger-Ellison syndrome.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used in adults for the short-term treatment of gastroesophageal reflux symptoms, such as heartburn and acid regurgitation.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used to reduce the secretion of stomach acid. It helps in treating the symptoms of gastroesophageal reflux disease (such as heartburn, pain when swallowing, or acid regurgitation), in the long-term treatment and prevention of recurrence of esophagitis, and in the prevention of gastric and duodenal ulcers in individuals who must take continuous anti-inflammatory drugs (NSAIDs).

Dosage form: tablets, enteric-coated

ATC: A02BC02

The medicine reduces the secretion of acid in the stomach. It is used in the treatment of reflux esophagitis, gastric and duodenal ulcer diseases, Helicobacter pylori infection (in combination with antibiotics), as well as in Zollinger-Ellison syndrome and other conditions related to excessive acid secretion.

Dosage form: tablets, enteric-coated

ATC: A02BC02

It is used in the treatment of stomach and intestinal diseases related to excess acid. It helps in the treatment of reflux esophagitis, gastric and duodenal ulcers, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome.

Dosage form: tablets, enteric-coated

ATC: A02BC02

The medicine is used in the treatment of stomach and intestinal diseases related to gastric acid, such as reflux esophagitis, gastric and duodenal ulcers, and Helicobacter pylori infection (in combination with antibiotics). It is also used in Zollinger-Ellison syndrome and other conditions involving excessive acid secretion.

Dosage form: tablets, enteric-coated

ATC: A02BC02

The medicine is used for the short-term treatment of symptoms of gastroesophageal reflux disease in adults, such as heartburn or acid regurgitation.

Dosage form: tablets, enteric-coated

ATC: A02BC02

The medicine is used for the treatment of, among others, gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers, as well as ulcers caused by Helicobacter pylori bacteria or anti-inflammatory drugs (NSAIDs). It also helps with excessive gastric acid secretion in Zollinger-Ellison syndrome.

Dosage form: capsules, hard, intestinal

ATC: A02BC01

The medicine is used for the treatment of, among others, gastroesophageal reflux disease (heartburn, pain, inflammation), gastric and duodenal ulcers, ulcers caused by Helicobacter pylori infection, as well as ulcers induced by anti-inflammatory drugs (NSAIDs). In children, it is used for the treatment of reflux and ulcers caused by Helicobacter pylori infection.

Dosage form: capsules, hard, intestinal

ATC: A02BC01